1. Home
  2. PTON vs BEAM Comparison

PTON vs BEAM Comparison

Compare PTON & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peloton Interactive Inc.

PTON

Peloton Interactive Inc.

HOLD

Current Price

$6.10

Market Cap

2.7B

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$27.69

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTON
BEAM
Founded
2012
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.0B
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
PTON
BEAM
Price
$6.10
$27.69
Analyst Decision
Buy
Buy
Analyst Count
11
12
Target Price
$7.89
$50.75
AVG Volume (30 Days)
9.0M
2.7M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
80.13
82.31
EPS
N/A
N/A
Revenue
N/A
$24,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.44
$33.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
33.33
52 Week Low
$3.65
$15.60
52 Week High
$9.20
$38.26

Technical Indicators

Market Signals
Indicator
PTON
BEAM
Relative Strength Index (RSI) 57.91 34.36
Support Level $5.96 $26.96
Resistance Level $6.96 $29.68
Average True Range (ATR) 0.24 2.45
MACD 0.04 -0.95
Stochastic Oscillator 66.48 5.82

Price Performance

Historical Comparison
PTON
BEAM

About PTON Peloton Interactive Inc.

Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product derives revenue from the portfolio of Connected Fitness Products and related accessories, as well as Precor-branded fitness products, delivery and installation services, Peloton Bike portfolio rental products, extended warranty agreements, branded apparel, and commercial service contracts. Subscription revenue is derived from monthly Subscription fees. The company generates maximum revenue from the Subscription segment. Geographically, the company derives a majority of its revenue from North America and the rest from International markets.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: